CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS · Delayed Price · Currency is USD
0.1350
-0.0310 (-18.67%)
At close: Jul 20, 2026
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $2.78 million as of July 21, 2026. Its market cap has decreased by -85.78% in one year.
Market Cap
2.78M
Enterprise Value
24.63M
Revenue
20.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
ChartMarket Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from 101.76M to 2.78M, a decrease of -97.27%. That is a compound annual growth rate of -11.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 2.78M | -84.11% |
| Dec 31, 2025 | 17.47M | -60.16% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mosaic ImmunoEngineering | 4.63M |
| GPL Holdings | 4.20M |
| AccuStem Sciences | 3.29M |
| Eastgate Biotech | 3.17M |
| Vaccinex | 3.08M |
| Institute of Biomedical Research | 3.02M |
| Bioxytran | 2.94M |
| Enzolytics | 2.90M |